BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in BridgeBio Pharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 179
- −13 vs. Q4 2021
- Shares held
- 143.3M
- +1.38M (+1.0%) vs. Q4 2021
- Total value
- $1.45B
- −$911.3M (−38.5%) vs. Q4 2021
- New holders
- 44
- 49 more added
- Sold out
- 57
- 59 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −59,838−100.0% | Sold out |
| Phocas Financial Corp. | 0 | $0 | 0.00% | −55,298−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −54,398−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −53,138−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −52,953−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −52,800−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −50,312−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −47,810−100.0% | Sold out |
| Renaissance Capital LLC | 0 | $0 | 0.00% | −42,974−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −40,372−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −33,228−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −31,467−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −9,213−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −19,733−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −19,363−100.0% | Sold out |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,928−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −14,689−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −13,253−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,300−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −7,660−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −3,728−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −3,246−100.0% | Sold out |
| Silvant Capital Management LLC | 0 | $0 | 0.00% | −2,581−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −1,125−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −354−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −253−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Institutional & Family Asset Management, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Grace Capital | – | – | – | – | Not filed |
| Tygh Capital Management, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |